ACCURATE DOSE
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| ACCU-DOSE | MARK L. ANDERSON | 303 S. MCKAY AVENUE SPRING VALLEY WI 54767 | ACCURATE DOSE;veterinary and medical medicament syringes to be used for treatment of animals; |
| ACCUDOSE | CENTRIX, INC. | 770 River Road Shelton CT 064845458 | ACCURATE DOSE;dental material cartridges; |
| ACCUDOSE | Botts, Lynne M. | 933 Paxton Lake Cove Loveland OH 45140 | ACCURATE DOSE;fluid delivery device for infants, comprising an oral dosing syringe, bottle and specialized nipple which delivers vitamins, concentrates, nutritionals, suspensions, prescribed or over-the-counter medicine along with other separate fluids to the recipient; |
| ACCUDOSE | VAPIUM INC | 661 University Avenue, Suite 1300 Toronto M5G0B7 Canada | ACCURATE DOSE;Smokeless cigar vaporizer pipes; Smokeless cigarette vaporizer pipe; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- This invention relates to apparatus and methods of delivering various compositions including medicaments to a variety of targets. The invention includes a dose administrator (1) which may be used for intranasal delivery of compositions or medicaments, such as live virus vaccines, to both humans and animals. An axial collapse prevention element (2) to prevent excessive axial deflection of the dose administrator (1) or a dose-location coordinate indicator (3) to facilitate the delivery of a dose to the desired target location may be coupled to the dose administrator (1). An intranasal probe (4) having a force dissemination contact surface (7) may be responsive to a first end of the dose administrator (1). The dose may be delivered from a conformable dose sequestration element (10) through an aperture which penetrates the dose delivery aperture element (5) and the dose may be caused to stream by coupling a stream delivery element (6) to the dose delivery aperture element (5). The force application element (12) which acts upon the dose may be separated from the dose by a fluid dose propellent (13). While the invention may be used for numerous applications, it specifically addresses the difficulties of delivering cold-adapted live equine influenza viruses intranasally to equids.